Nilotinib in Parkinson's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study will assess the safety and tolerability of daily oral administration of nilotinib (150-300mg once daily) in Parkinson\'s Disease.
Epistemonikos ID: 82ef8404b96f209ac94345faac57ad0a23151b89
First added on: May 20, 2024